other glp 1 receptor agonists GLP-1 for individualized treatment of type 2 diabetes mellitus Current Insights, Advantages and Challenges

Peptide binding at the GLP-1 receptor

Self-reported community protocols commonly describe once-daily dosing with on/off cycling, motivated partly by the absence of any long-term human safety data and partly by a community perception of diminishing returns or tolerance over continued use

doi:10.2991/jegh.k.190816.001 Lajoie AC, Lafontaine AL, Kimoff RJ, Kaminska M

found that intraperitoneal injection of exendin-4 increased the number of BrdU-positive progenitor cells in the subventricular zone (33), indicating that exendin-4 could compensate for the loss of dopaminergic neurons in the PD model by promoting the formation of substantia nigra neurons

Ensure you are hydrated and getting enough sleep before adding supplements to the mix